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Abstract
Background: Previously we reported extensive gene expression reprogramming during epithelial to mesenchymal
transition (EMT) of primary prostate cells. Here we investigated the hypothesis that specific histone and DNA
methylations are involved in coordination of gene expression during EMT.
Results: Genome-wide profiling of histone methylations (H3K4me3 and H3K27me3) and DNA methylation
(DNAMe) was applied to three cell lines at different stages of a stepwise prostate cell model involving EMT and
subsequent accumulation of malignant features. Integrated analyses of epigenetic promoter modifications and
gene expression changes revealed strong correlations between the dynamic changes of histone methylations and
gene expression. DNA methylation was weaker associated with global gene repression, but strongly correlated to
gene silencing when genes co-modified by H3K4me3 were excluded. For genes labeled with multiple epigenetic
marks in their promoters, the level of transcription was associated with the net signal intensity of the activating
mark H3K4me3 minus the repressive marks H3K27me3 or DNAMe, indicating that the effect on gene expression of
bivalent marks (H3K4/K27me3 or H3K4me3/DNAMe) depends on relative modification intensities. Sets of genes,
including epithelial cell junction and EMT associated fibroblast growth factor receptor genes, showed
corresponding changes concerning epigenetic modifications and gene expression during EMT.
Conclusions: This work presents the first blueprint of epigenetic modifications in an epithelial cell line and the
progeny that underwent EMT and shows that specific histone methylations are extensively involved in gene
expression reprogramming during EMT and subsequent accumulation of malignant features. The observation that
transcription activity of bivalently marked genes depends on the relative labeling intensity of individual marks
provides a new view of quantitative regulation of epigenetic modification.
Background
Carcinomas arise from normal epithelial tissues in a multi-
step process. The breakdown of epithelial cell homeostasis
leading to aggressive cancer progression corresponds with
the loss of epithelial characteristics and the acquisition of
migratory phenotypes, referred to as epithelial to
mesenchymal transition (EMT), and is believed to be a
crucial event in tumor progression and endows cancer
cells with invasive and metastatic competence [1-3]. In a
transformation attempt, however, we have observed com-
plete EMT from benign prostate epithelial cells (EP156T)
to cells with a mesenchymal phenotype (EPT1) without
malignant transformation [4]. To achieve transformed
prostate cells, EPT1 cells were kept growing in extended
saturation density culture to select for cells overriding
quiescence. Many foci formed in EPT1 cell monolayers.
Cells (EPT2) were isolated from the foci and were found
to have acquired several malignant features, such as
anchorage independent growth, much higher abilities to
proliferation at confluence, increased resistance to
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apoptosis and much lower dependence on external growth
factors compared with EP156T and EPT1 cells. Both cyto-
genetic and DNA fingerprinting analyses revealed genetic
identity of the three cell lines and confirmed progeny
authenticity of the cell model. EPT2 cells did not, however,
form tumors in animals suggesting their being at an early
transformation stage and additional induction is required
for full malignant transformation [5]. This stepwise cell
model provides a good opportunity to understand the
mechanisms of EMT and its role in subsequent accumula-
tion of malignant features in vitro.
Epigenetic modifications, especially histone and DNA
methylations, have a large impact on the regulation of
gene expression and are critical in establishing patterns
of gene repression during development [6]. Previous gen-
ome-wide maps of histone H3 lysine 4 and lysine 27 tri-
methylation (H3K4me3 and H3K27me3) showed a very
clear correlation between H3K4me3 and expressed genes
and H3K27me3 and repressed genes in embryonic stem
cells [7-10], T cells [11], hematopoietic stem cells/pro-
genitor cells [12] and in prostate cancer cells [13]. DNA
methylation (DNAMe) is a widely accepted gene expres-
sion silencing mark and was considered as coupled to
H3K27me3 through enzymatic interaction [6]. Genome-
wide mapping of DNAMe, however, revealed that most
strong CpG island promoters are unmethylated even
when they were inactive, and low CpG content promo-
ters are predominantly methylated although this methyla-
tion does not preclude gene expression [14].
Furthermore, global profiling of epigenetic silencing
marks in prostate cancer cells showed that H3K27me3
modified loci excluded DNA hypermethylation [15,16].
All these recent findings suggest that the complex epige-
netic regulation based on histone methylation and DNA
methylation is far from understood.
Epigenetic analysis of genes critical for EMT has been
performed, but limited to very few genes including
E-cadherin. Evidence was first presented that DNA
hypermethylation may be a mechanism of E-cadherin
inactivation [17]. However, a recent report showed that
reversible histone modifications rather than DNA
demethylation are the predominant factors in reactiva-
tion of E-cadherin expression [18]. Apart from this
E-to-N cadherin switch, we also found that P-cadherin,
a basal cell-specific epithelial mark [19], is significantly
down-regulated in EPT1 cells [4]. Regarding the epige-
netic modifications of N-cadherin and P-cadherin genes,
very little information is available. Considering the con-
flicting observations above and that the epigenetic regu-
lation of most of the critical genes of EMT is unknown,
genome-wide profiling of the epigenetic modifications
during EMT is highly desirable.
Taking advantage of the striking gene expression
reprogramming associated with EMT and the
subsequent acquisition of defined malignant features of
our present model and comprehensive analysis of his-
tone and DNA methylations based on the same promo-
ter microarray platform, we describe here the dynamic
epigenetic change patterns of critical genes for EMT
and provide the first blueprint of epigenetic modification
during EMT in prostate cells.
Results
Genome-wide profiling of histone methylation, DNA
methylation and gene expression in prostate cells
Profiling of histone and DNA methylation of EP156T,
EPT1 and EPT2 cells was performed using chromatin
immunoprecipitation (ChIP) and methylation DNA immu-
noprecipitation (MeDIP) protocols followed by human
promoter microarrays containing 488 k 60-mer probes,
which cover 5.5 kb upstream to 2.5 kb downstream of the
transcription start sites of 17,000 defined human RefSeqs
(Figure 1A). Histone or DNA modification intensities were
indicated by the normalized value of log2 ratios between IP
signals and control signals. Probes with intensity above 1
were considered as significant. The quality of human pro-
moter microarray hybridizations was validated by quantita-
tive PCR (Figure S1 in Additional file 1), showing that
most of the detected regions have similar modification pat-
terns as found by promoter microarray profiling.
As shown in Figure 1B, near 80% of all significant
H3K4me3 probes were in common between EP156T &
EPT1 and EPT1 & EPT2 cells, suggesting that H3K4me3
modification patterns were quite similar between these
cells, thus underscoring the high reliability of the platform.
Much fewer common H3K27me3 and DNAMe probes
were detected among EP156T, EPT1 and EPT2 cells, sug-
gesting that these cell lines have very different modifica-
tion patterns of H3K27me3 and DNAMe. Total intensities
including the promoter and gene body were used to define
epigenetically marked genes based on a threshold of 7.
Calculation of significant probes per marked gene sug-
gested that the modification level of DNA methylation was
much lower than that of both H3K4me3 and H3K27me3
in all the three cell lines (Figure 1B).
Global gene expression analysis was achieved using
Agilent 44 k human DNA microarrays containing 17596
unique gene symbols. The gene expression levels were
indicated by the normalized signal intensities with cutoff
5 for the lowest and 16 for the highest in log2 values
(Figure 1C). Previous studies showed that around 25%
of genes were highly expressed and 50% of genes were
repressed in both normal and cancer human cells
[10,16,20]. The median values of gene expression in
EP156T, EPT1 and EPT2 cells were quite similar and all
were around 7.5 (Additional file 2). So we defined active
genes with intensities above 7.5, while silent genes dis-
played intensities below 7.5.
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Comparing the gene lists of the promoter microarrays
and gene expression microarrays, 14212 genes were cov-
ered in both arrays and were used for further analysis.
Approximately 60%, 26% and 22% of all genes were
marked by H3K4me3, H3K27me3 and DNAMe, respec-
tively, in all three cell lines (Figure 1B and Additional
file 3). To further validate the ChIP-chip and MeDIP-
chip data, we selected a set of housekeeping genes [21]
and found that these genes are preferably modified by
H3K4me3 but not by H3K27me3 and DNA methylation
(Table S1 in Additional file 1), which is consistent with
previous observations [22].
DNA Methylation is per se only a weak mark of
gene repression
It is established that H3K4me3 is an active mark while
both H3K27me3 and DNAMe are marks of silent gene
expression [6,23]. We compared the three kinds of epi-
genetic modifications with gene activities in all three
prostate cell lines, as shown for EP156T cells in Figure 2A
and 2B. As expected, the expression level of the H3K4me3
marked gene group was much higher than the total level
(with median values 9.1 versus 7.5, p < 0.05), and the
expression level of the H3K27me3 marked gene group was
much lower than the total level (with median values 5.8
versus 7.5, p < 0.05). Surprisingly, the median expression
level of the DNA methylated gene group was very close to
the total level (6.8 versus 7.5), suggesting that DNA
methylation, which was regarded as a silencing epigenetic
mark of gene activity, showed only slight correlation with
gene repression.
The weak correlation between DNA methylation and
gene activities was also confirmed by scatter plot analy-
sis, as exemplified for EP156T cells. A very evident posi-
tive and negative correlation was found between
H3K4me3 and H3K27me3 and gene expression, respec-
tively (Figure 2C). Up to 78% of expressed genes were
modified by H3K4me3, and among H3K4me3 marked
genes, 72% of them were expressed. In contrast, 92% of
expressed genes were non-H3K27me3 modified, and
Figure 1 Overview of genome-wide profiling of histone methylation, DNA methylation and gene expression of prostate cells. (A)
Flowchart of ChIP-chip, MeDIP-chip and gene expression microarray profiling of EP156T, EPT1 and EPT2 cells. (B) Summary of detected probes
and genes that were modified by H3K4me3, H3K27me3 and DNAMe in EP156T, EPT1 and EPT2 cells. Around 20%, 10% and 3% of probes
detected significant H3K4me3, H3K27me3 and DNAMe modification, respectively, in the three cell lines. (C) Gene distribution according to the
expression levels in EP156T cells. Genes with expression level above 7.5 were considered as expressed genes, genes with expression level below
7.5 were considered as silenced genes.
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80% of H3K27me3 modified genes were silent genes.
However, among DNA methylated genes, 42% of genes
were expressed and 58% were silenced. Similar relation-
ships were also found in EPT1 and EPT2 cells.
DNA methylation is a strong silencing mark for genes
modified only by DNAMe without H3K4me3
It was very surprising to find that DNA methylation cor-
related only weakly to gene repression, since DNA
methylation is established in silencing of many indivi-
dual genes [23]. Indeed, we also found that most of the
top ten methylated genes were completely silenced in all
the three cell lines (see Table S2 in Additional file 1),
including RUNX3, whose promoter has been found
previously to be DNA hypermethylated in prostate can-
cer patients [24]. Considering that up to 60% of genes
were modified by H3K4me3, we selected genes that
were modified only by DNA methylation without the
Figure 2 Correlation between H3K4me3, H3K27me3 and DNAMe modifications and gene activities. (A) Genes were ranked according to
their expression levels in EP156T cells. The percentages shown along the × axis correspond to expressed genes for each kind of modification. (B)
Comparison of gene activities with different epigenetic modifications in EP156T cells. Gene activities were indicated as median values of gene
expression levels of each kind of genes. (C) Scatter plots between gene expression levels and epigenetic modification levels in EP156T cells.
Comparison of the gene distribution (D) and the median values of gene expression (E) between genes marked by DNAMe without additional
H3K4me3 and all genes marked by DNAMe in EP156T cells. (F) Scatter plots between DNAMe modification intensities and gene expression levels.
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additional H3K4me3 and compared their methylation
intensities and gene expression levels. As exemplified for
EP156T cells in Figure 2D, among 4211 DNAMe
marked genes, 1736 genes were considered DNAMe
marked only. The expression levels of these DNAMe
only marked genes were significantly lower than the
levels of all genes (5.8 versus 7.5 in median values, p <
0.05) (Figure 2E). Scatter plots showed that 81.5% of
DNAMe only marked genes were silent genes, which is
much higher than the percentage of all DNAMe marked
genes (58.0%) (Figure 2F), suggesting that DNA methy-
lation is a strong silencing mark of gene expression
when it is not co-modified by the active H3K4me3
mark. Comparable results were found also in EPT1 and
EPT2 cells.
Bivalent H3K4/K27me3 is a repressive mark and
H3K4me3/DNAMe is an activation mark in prostate cells
Bivalent epigenetic modification was first discovered in
embryonic stem cells when genes were modified by both
H3K4me3 and H3K27me3 and showed low transcription
activity [7-10]. Here, we examined the association
between bivalent H3K4/K27me3 as well as H3K4me3/
DNAMe and gene expression in somatic cells. As shown
in Figure 3A, H3K4/K27me3 modified genes have lower
expression levels than all genes and more silenced genes
(67%) than expressed genes (33%), suggesting it is a
combined silencing mark. This is consistent with pre-
vious observations that H3K4/K27me3 bivalent promo-
ters showed low transcription activity. However, genes
marked by H3K4me3/DNAMe have expression levels
higher than all genes (Figure 3A) and less silenced genes
(42%) than expressed genes (58%), suggesting that
H3Kme3/DNAMe is a combined activation mark rather
than a silencing mark. Scatter plots also showed more
silent genes than active genes in the H3K4/K27me3
group (Figure 3B), and more active genes than silent
genes in H3K4me3/DNAMe group (Figure 3C). Com-
parable results were found also in EPT1 and EPT2 cells.
It is very interesting to find that genes marked by
H3K4me3/DNAMe are preferentially active but not
silent genes, which means that misleading conclusions
will be drawn if we predict the activities of DNA methy-
lated genes without taking into consideration the
H3K4me3 modification.
There are pronounced differences between the
H3K27me3 only and H3K4/K27me3 groups although
both are silencing marks (Figure 3B). The percentage
of silent genes is much higher (94%) among the
H3K27me3 only marked genes than among the H3K4/
K27me3 bivalent genes (66%, p < 0.05). Furthermore,
most of the silenced genes marked by H3K27me3 have
very low expression level (< 5.8). It is a reasonable esti-
mate that H3K4/K27me3 marked genes have moderate,
but not very low activity in prostate cells. In contrast,
most of the DNAMe only genes (81.4%) are silent genes,
and more H3K4me3/DNAMe marked genes (58%) are
active genes (p < 0.05) (Figure 3C). This finding may
explain why DNA methylation correlated only weakly to
gene silencing at the global level since most (2475 out
of 4211) of the DNAMe genes were co-modified by the
active mark H3K4me3 and therefore were more likely to
become expressed.
Transcription activities of genes with bivalent marks
depend on the relative intensities of active and
repressive marks
Previous work found that H3K4/K27me3 bivalently
modified promoters showed low transcription activity
and argued that the repressive effect of H3K27me3 is
epistatic to the activating effect of H3K4me3 in a biva-
lent domain [7,8]. However, we have observed that most
of the H3K4/K27me3 marked genes have stronger modi-
fication signal intensities of H3K27me3 than H3K4me3
and propose that the transcription activities of genes
with double marks are reflected by the relative signal
intensities of active and repressive marks.
To examine this hypothesis, we quantitatively calcu-
lated the modification signal intensities of genes with
both active and silencing marks. We considered
H3K4me3 intensity as the positive value and H3K27me3
or DNAMe intensities as negative values. The net inten-
sity of epigenetic modifications is the sum of positive and
negative values. The net epigenetic modification intensi-
ties and the gene expression levels of both H3K4/
K27me3 and H3K4me3/DNAMe marked genes were
plotted for the three cell types (Figure 4). Very strikingly,
in the H3K4/K27me3 gene group, as exemplified for
EP156T cells, up to 92% of the expressed genes have
positive net intensity, which means that most of them
have stronger intensity of H3K4me3 than of H3K27me3.
When it comes to genes with negative net intensities,
meaning that the intensity of H3K27me3 is stronger than
of H3K4me3, most (87%) of them are silent genes.
Similar patterns were observed for H3K4me3/DNAMe
modified genes. Most (86%) of the expressed genes have
stronger modification signal intensities of H3K4me3 than
DNAMe, and most (79%) of the genes with negative net
intensity are silent genes.
The finding that the transcriptional activity of genes
with double marks depends of the relative intensities of
active and repressive marks suggested that there is not
any dominant effect of H3K27me3 over H3K4me3 per
se. Individual genes are more likely to be active genes if
the modification intensities of H3K4me3 are stronger
than H3K27me3, implying more modified sites in the
same region. In genes with H3K4/H3K27me3 modifica-
tion, the sum of the H3K27me3 signal intensities
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(negative values, -25563) is higher than the sum of the
H3K4me3 intensities (positive values, 16682), while in
genes with H3K4me3/DNAMe, the sum of the DNAMe
(negative values, -3885) is lower than the sum of the
H3K4me3 signal intensities (positive values, 35335),
which may explain, at the global level, why H3K4/
H327me3 marked genes showed somewhat lower activ-
ity while H3K27me3/DNAMe marked genes showed
higher transcription activity.
H3K4me3 and DNAMe often co-modified genes but at
separate regions
Bivalently marked genes as described above have been
defined when their promoters contained two different epi-
genetic marks [7,9]. The fine patterns of co-modification
have remained unsettled since one gene might be modified
by two marks at two separate regions. Here, we examined
the co-localization of double marks with bivalently marked
probes that were detected with significant intensities for
Figure 3 Correlation between bivalent modifications and gene activities in EP156T cells. (A) Comparison of gene activities of H3K4me3/
K27me3 and H3K4me3/DNAMe marked genes and all (Total) genes. (B) Comparison of gene activities between H3K4me3/K27me3 bivalently
marked genes and H3K27me3 only marked genes using scatter plots. Genes below the lower threshold in the panel to the right belonged to the
VL group. (C) Comparison of gene activities between bivalent H3K4me3/DNAMe marked genes and DNAMe only marked genes using scatter plots.
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both marks. Clustered bivalent probes were defined when
at least 3 bivalent probes mapped to one gene to distin-
guish them from more separated sporadic bivalent probes.
As shown in Figure 5A, the bivalent probes with
lowest and highest frequency at the global level were
H3K4/K27me3 and H3K4me3/DNAMe, respectively.
However, bivalent H3K4/K27me3 marks much more
often belonged to clustered probes compared to
H3K4me3/DNAMe marks, which means that many of
the H3K4/K27me3 sites colocalized in certain genes,
and most of the H3K4me3/DNAMe sites were distrib-
uted separately with limited co-localization. Actually,
we found that many of the significant H3K4me3 and
H3K27me3 probes cluster together and form big
islands, and most of the bivalent H3K4/K27me3 probes
were accommodated into these islands (example
in Figure 5B), while significant DNAMe probes
were often separately distributed with very few clus-
tered DNAMe sites, and the frequency of clustered
H3K4me3/DNAMe marks was even lower (Figure 5C).
We concluded that in prostate cells, DNAMe labeled
probes were more often co-labeled by H3K4me3 than
by H3K27me3, but H3K4/K27me3 probes much more
frequently clustered within certain genes than
H3K4me3/DNAMe probes.
When one gene was modified by both H3K4me3 and
DNAMe, such as bivalent genes described in Figure 3
most of the DNAMe marked regions were separated
from H3K4me3 islands, with very few bivalent
H3K4me3/DNAMe probes (Figure 5D).
Figure 4 Correlation between net signal intensity of epigenetic modifications and gene activities of bivalently marked genes. The net
intensities of H3K4me3 versus H3K27me3 or H3K4me3 versus DNAMe are shown along the X-axis. Gene expression levels are shown along the
Y-axis. Genes above the horizontal lines are expressed genes. Genes below horizontal lines are considered as repressed genes. Genes to the left
of vertical lines are stronger labeled by active marks. Genes to the right of vertical lines are stronger labeled by repressive marks.
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Increased histone methylation and decreased DNA
methylation during EMT
It is interesting to know how epigenetic marks change
from EP156T to EPT1 cells during EMT, in which striking
cell biological and morphological changes were observed.
The changed epigenetic modification was calculated as the
difference between the intensity of epigenetic marks in
EPT1 cells versus EP156T cells and indicated as delta (Δ).
Only genes with Δ values above 5 were considered as
differentially epigenetic modified genes. As shown in
Figure 6A and Additional file 4, 28.5% of the analyzed
genes have increased H3K4me3 marks (4072), while much
fewer genes have decreased H3K4me3 marks (534) during
EMT. Similar change was also found for the H3K27me3
mark with near twice as many genes with increased marks
as genes with decreased marks. In contrast, the DNAMe
mark changed in a much lower number of genes, and then
more genes exhibited decreased DNAMe marks (706) than
increased DNAMe marks (166). The observation of
increased H3K4me3 and H3K27me3 modification and
decreased DNAMe modification during EMT is also
shown in the detected significant probes in EP156T and
EPT1 cells (Figure 1B). There were more significant probes
of H3K4me3 and H3K27me3 marks and less of DNAMe
marks detected in EPT1 cells than in EP156T cells.
Gene ontology was performed to find what kinds of
genes have changes of epigenetic modification during
EMT. The most enriched GO terms in genes with
increased H3K4me3 marks are metabolic process, while
the most enriched GO terms in genes with decreased
H3K4me3 mark are developmental process (Figure 6B).
Development related processes are enriched in genes
with both increases and decreases of either H3K27me3
or DNAMe marks (Additional file 4).
Dynamic changes of H3K4me3 or H3K27me3 but not
of DNAMe correlate to changes of gene expression
during EMT
To understand epigenetic regulation of EMT at the glo-
bal level, we examined the dynamic changes of both epi-
genetic modification and gene expression during EMT.
The changed gene expression was also calculated as the
Δlog2 value between two cell lines. Only genes with Δ
log2 values above 2 were considered as differentially
expressed genes. There were 172 up-regulated and 307
down-regulated genes during EMT (Additional file 5).
Gene ontology analysis showed that these genes were
highly enriched in processes such as ectoderm and
epithelium development, cell migration and adhesion
(Additional file 5), in which EMT is widely involved [1].
Figure 5 Examination of bivalently marked sites. (A) Summary of bivalent sites and clustered sites in EP156T, EPT1 and EPT2 cells. (B)
Epigenetic modifications of the androgen receptor (AR) gene in EP156T cells. The red box indicates a bivalent H3K4/K27me3 site. The green box
indicates H3K4/K27me3/DNAMe trivalent sites. (C) Epigenetic modifications of the prostaglandin F receptor (PTGFR) gene in EPT1 cells. The green
box shows a bivalent H3K4me3/DNAMe site. (D) Epigenetic modifications of the PAX9 gene in EPT2 cells. The green box shows DNAMe only
modified region, the red box shows an H3K27me3 only modified region and blue boxes show H3K4me3 only modified regions.
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Examining the changed epigenetic modifications among
these changed genes, we found that most of the up-
regulated genes have increased H3K4me3 and most of
the down-regulated genes have decreased H3K4me3
modifications (p < 0.05) (Figure 7A). In contrast, most
of these up-regulated genes have decreased H3K27me3
and most down-regulated genes have increased
H3K27me3 (p < 0.05). However, there were no signifi-
cant differences between genes with increased or
decreased DNA methylation in either up-regulated or
down-regulated genes.
We also examined the changed gene expression of genes
with changed epigenetic modifications. The expression
levels of the top 100 epigenetically changed genes are
shown in Figure 7B. It is very evident that most genes
with increased H3K4me3 were up-regulated during
EMT, while genes with decreased H3K4me3 were
down-regulated during EMT. Opposite changes were
found for H3K27me3, in which most of the genes with
increased H3K27me3 were down-regulated during
EMT, while genes with decreased H3K27me3 were
up-regulated during EMT. However, there was no
Figure 6 Analysis of genes with changed epigenetic marks from EP156T to EPT1 cells during EMT. (A) Comparison of numbers of genes
with different kind of epigenetic mark changes. (B). Gene ontology (GO) analysis of genes with epigenetic mark changes during EMT.
Figure 7 Correlation between changed epigenetic modifications and changed gene expression during EMT. (A) Scatter plots of the
changed epigenetic modification of genes that were differentially expressed between EP156T and EPT1 cells. (B) Comparison of the expression
patterns of the top 100 epigenetically changed genes during EMT.
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significant correlation between changed DNA methyla-
tion and changed gene expression during EMT.
Epigenetic switches of critical EMT-associated genes
EP156T cells were strikingly reprogrammed during EMT
with loss of multiple epithelial markers and gain of
mesenchymal features. One of the most characterized
switches is the cadherin switch with down-regulation of
E-cadherin and gain of N-cadherin. Additionally, we
found that P-cadherin, a basal cell-specific epithelial
mark [19], is significantly down-regulated in EPT1 cells
[4]. Based on the epigenetic profiling, we found that the
epigenetic promoter modifications of these three cadher-
ins changed significantly among EP156T, EPT1 and
EPT2 cells (Figure 8A). For P-cadherin, its promoter
was dominated by H3K4me3 and it was highly
expressed in EP156T cells. Following EMT the
H3K4me3 modification decreased and the repressive
marks H3K27me3 and DNAMe became stronger than
H3K4me3 and the expression level of P-cadherin
decreased significantly. During the transition from EPT1
to EPT2 cells, H3K4me3 modifications completely dis-
appeared but H3K27me3 increased, and the expression
of P-cadherin decreased further. In contrast, the N-cad-
herin promoter was dominated by repressive marks in
EP156T cells, but it became H3K4me3 dominated as the
expression level strongly increased in EPT1 cells after
EMT. During accumulation of malignant features,
H3K4me3 decreased and repressive marks became
stronger again. Concomitantly, the expression of N-cad-
herin reversed to silencing again. For E-cadherin, the
epigenetic switch was not significant although the gene
expression clearly decreased during EMT. However, the
continued decrease of E-cadherin expression from EPT1
to EPT2 cells was accompanied by significant epigenetic
switches with complete disappearance of H3K4me3 and
increase of H3K27me3. We therefore can report an
extensive consistency between epigenetic switches and
gene expression switches of N-cadherin and P-cadherin
during both EMT and early transformation steps. For E-
cadherin this consistency was found only at the early
transformation step, but not at the EMT step, suggest-
ing that the E-cadherin promoter is affected by different
regulatory subprograms.
Fibroblast growth factor receptor 1 (FGFR1) is a
known EMT inducer whose activation can lead to irre-
versible prostate adenocarcinoma and EMT [25]. Very
interestingly, there is also a switch between FGFR1 and
another FGFR member FGFR3. The gene expressions
between FGFR1 and FGFR3 were observed as mutually
exclusive in colorectal carcinoma cells and indicated
that their reciprocal relationship plays an important role
in the progression of the carcinomas [26]. FGFR2 is also
involved in EMT by an alternative splicing event
between mutually exclusive exons IIIb and IIIc. The
FGFR2-IIIb splice variant is exclusive to epithelial cells,
while FGFR2-IIIc is expressed in mesenchymal cells
[27]. In our prostate cell model, we found that the acti-
vation of FGFR1 was accompanied by significant down-
regulation of FGFR3 and FGFR2 during EMT. This
switch was kept from EPT1 to EPT2 cells (Figure 8B).
In EP156T cells, the promoter of FGFR1 was strongly
modified by H3K27me3 and DNAMe, and the transcrip-
tion was completely silenced, while H3K4me3 modifica-
tion increased strongly, but DNA methylation decreased
and H3K27me3 disappeared during EMT, accompanied
by activation of FGFR1 expression. In contrast, the pro-
moter of FGFR2 underwent the opposite switch with
decreased H3K4me3 and increased H3K27me3 during
EMT as the expression of FGFR2-IIIb was down-regu-
lated. The epigenetic switches in the promoter of
FGFR3 involved only H3K27me3 and DNA methylation,
but not H3K4me3. In EP156T cells, the promoter was
modified by H3K27me3 and DNA methylation at very
low levels and FGFR3 was expressed at middle level,
H3K27me3 modification strongly increased during EMT
and FGFR3 became completely silenced in EPT1 cells.
From EPT1 to EPT2 cells, the promoter of FGFR1 was
continually dominated by H3K4me3 and the expression
was still active. The promoter of FGFR3 was continually
dominated by H3K27me3 and the expression was still
repressed.
Identification of genes with consistent epigenetic
switches and expression switches during EMT
Apart from the cadherins and FGFRs described above, we
also identified multiple other important EMT-associated
genes with consistent changes of histone modifications
according to their differential expression (Additional file
6). We examined four kinds of combinations including
increased H3K4me3 & up-regulated genes, decreased
H3K4me3 & down-regulated genes, increased H3K27me3
& down-regulated genes and decreased H3K27me3 & up-
regulated genes. Very interestingly, many of these genes
have significant changes of both H3K4me3 and
H3K27me3 marks. For example, all of the top 9 genes
(LAD1, RBM35A, FXYD3, IGSF91, GJB2, EVA1, PCSK9,
OVOL2 and RNF43) with increased H3K27me3 marks
were accompanied by decreased H3K4me3 modification,
and all of the top 5 genes (FGFR1, FOXF2, CDH11,
ATOH8 and BDNF) with decreased H3K27me3 were
accompanied by increased H3K4me3 (Additional file 6). In
addition, many of them were involved in cell junctions,
such as GJB2, 4, 5 and 6 of gap junctions, CDH2, 3 and 11
in cadherin junctions, DSC3, DSG3 PKP1 and PKP3 of
desmosomes, as well as KRT5, which is expressed
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especially in the basal layer of the epidermis. All these
coordinated epigenetic changes and expression changes of
these cell junction genes indicate that histone methylation
is very critical in regulating the breakdown of epithelial
cell homeostasis and leading to the loss of epithelial char-
acteristics and the acquisition of migratory phenotypes.
Discussion
This is the first genome-wide study of histone and DNA
methylation during EMT with subsequent accumulation
of malignant features. EP156T are primary benign pros-
tate epithelial cells, EPT1 are progeny cells that under-
went EMT without malignant transformation. EPT2
Figure 8 Epigenetic modification and gene expression of cadherin and FGFR families during EMT and early transformation. (A)
Epigenetic modification of the promoters (left) and gene expression (right) of E-cadherin (CDH1), N-cadherin (CDH2) and P-cadherin (CDH3) in
EP156T, EPT1 and EPT2 cells. (B) Epigenetic modification of the promoters (left) and gene expression (right) of FGFR1, FGFR2 and FGFR3 in
EP156T, EPT1 and EPT2 cells.
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cells were subsequently derived from EPT1 cells. EPT2
cells acquired several well-defined malignant features,
including anchorage independent growth, resistance to
apoptosis and independence of external growth factors
[5]. The study revealed consistent relationships between
promoter modifications and gene expression patterns
both at the global level and concerning many individual
genes previously known to play important roles in these
processes. It therefore appears that epigenetic modifica-
tions are involved in the coordination of entire gene
expression programs during EMT and early transforma-
tion steps. However, EPT2 cells represent only early
transformation and did not form tumors in tested ani-
mals [5]. The lack of tumorigenicity represents a limita-
tion of this study. Work is ongoing to identify the
factors that restrict tumorigenicity in the EPT2 cells
even after their acquisition of anchorage independent
growth and self sufficiency of growth factors.
Most protein coding genes are modified by at least
two of the H3K4me3 and H3K27me3 or DNAMe marks
[7-11,14,28,29]. One observation of particular interest is
that the net modification signal intensities of activating
and repressive marks were quantitatively associated with
the modified gene activities. The transcriptional level of
genes with bivalent marks depends on the relative inten-
sities of active and repressive marks. This is in contrast
to an alternative model of “dominance” of one type of
mark over the other [7,8]. Actually, when it comes to
genes with stronger H3K4me3 intensity than H3K27me3
intensity, these genes are more likely expressed genes.
Hence, it is very important to examine both active and
silent marks before correlation of gene expression activ-
ities and epigenetic modifications.
It is widely accepted that DNA methylation is a
repressive mark of gene activity. However, this concept
may have to be modified in several important aspects.
For example, DNA methylation at certain upstream or
downstream promoter sites was associated with higher
expression, which may be due to the inhibition of bind-
ing of silencers [30]. Complexity also occurs when DNA
methylated sites belong to the intragenic region where it
can relate to both gene activity and silencing [31]. We
found that DNA methylation is a strong silencing mark
only when genes are modified by DNAMe without con-
comitant H3K4me3, and DNA methylation correlates
only slightly to promoter repression at the global level.
Furthermore, a gene modified by both DNAMe and
H3K4me3 is more likely to be activated. A recent report
also found that methylation of DNA and not H3K4 cor-
related to suppressed transcription, while gene transcrip-
tion was only slightly reduced when both DNA and
H3K4 were methylated [29].
We found that DNA methylation has less significant
effect than histone methylation on prostate cells during
EMT. Firstly, the number of significant DNAMe-detecting
probes was much less than for H3K4me3 and H3K27me3.
Secondly, the modification level of DNAMe was much
lower than for both H3K4me3 and H3K27me3 in all the
three cell lines. Thirdly, more H3K27me3 marked genes
(94%) than DNAMe marked genes (81.5%) were repressed,
indicating that DNA methylation correlates weaker than
H3K27me3 with gene repression. Lastly and most impor-
tantly, there was no significant correlation between the
changed DNAMe modification and changed gene expres-
sion. Actually, the weak correlation between DNA methy-
lation and gene silencing has been observed also when
many DNA methylation events in cancer occurred at the
promoters of genes that were already repressed in the nor-
mal tissue, before transformation [32]. All these findings
were different from the prevailing view that DNAMe plays
the critical role in silencing gene expression [6,23]. Two
technical limitations should be noted, however, since we
detected methylated promoter DNA using an antibody
against 5’-methylcytidine, which preferably recognizes
methylated CpG islands with threshold sensitivity [32].
However, most CpG islands in the genome are not methy-
lated and methylated DNA is more abundantly detected in
repeat sequences compared to promoters of protein cod-
ing genes [29]. The Agilent promoter array used in our
profiling could be associated with loss of some of the CpG
islands present in the CpG island array.
More than half of the protein coding genes were modi-
fied by both H3K4me3 and DNAMe in our prostate cell
lines, Fouse et al and Li et al also found that 40% and
66%, respectively, of DNAMe marked genes were co-
modified by H3K4me3 [28,29], which seems in conflict
with an observation that there is a strong anti-correlation
between DNA methylation and the presence of H3K4me
[6]. This apparent conflict may be explained by our pre-
sent examination at higher resolution which shows that
DNAMe and H3K4me3 marks indeed tend to localize at
different sites within the same promoter. This supports
that DNAMe and H3K4me3 modifications are really
mutually exclusive at the same sites [6], but both marks
can colocalize in different regions of the same gene
bodies.
Epigenetic regulation of E-cadherin has been
addressed for a long time and in many labs with differ-
ent results. Promoter DNA hypermethylation was the
first reported epigenetic silencing mechanism of E-cad-
herin [17]. Later studies pointed to H3K27me3 rather
than DNA demethylation in E-cadherin repression
[18,33]. Our findings indicate that epigenetic regulation
of the E-cadherin promoter varied at different stages.
During EMT in our cell culture model, none of the
H3K4me3, H3K27me3 or DNAMe marks were changed
in the promoter of E-cadherin even though the tran-
scription of E-cadherin was significantly down-regulated.
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During subsequent accumulation of malignant features,
we detected complete loss of H3K4me3 accompanied
with full silencing of E-cadherin expression.
Conclusions
EMT is a crucial event in tumor progression. This work
presents the first blueprint of epigenetic modifications
during EMT in prostate cells and shows that specific
histone methylations are extensively involved in gene
expression reprogramming during EMT and subsequent
accumulation of malignant features. Many genes, espe-
cially epithelial cell junction genes, showed corresponding
changes concerning epigenetic modifications and gene
expression during EMT. The observation that transcrip-
tion activity of bivalently marked genes depends on the
relative labeling intensity of each mark provides a new
view of quantitative regulation of epigenetic modification.
Methods
Cell lines and cell culture
The prostate cell lines EP156T, EPT1 and EPT2 were
grown in modified MCDB153 medium as described [4,5].
Chromatin immunoprecipitation (ChIP)
ChIP was performed according to the Agilent ChIP-chip
protocol with modifications as previously described
[13]. To immunoprecipitate chromatin, 6 × 107 cells
were treated with 1% formaldehyde at room tempera-
ture for 10 min followed by quenching with 0.125 M
glycine. Cells were lysed and the nuclei were sonicated
under conditions yielding DNA fragments ranging from
200 to 800 basepairs. Five percent of the sonicated
material was saved as whole cell extract. Sonicated
lysate was divided into three equal volumes and immu-
noprecipitated with specific or non-specific antibody
bound to protein A magnetic beads (Invitrogen) over-
night at 4°C with rocking. Antibodies used were against:
H3K4me3 (Abcam no. ab8580) or H3K27me3 (Abcam
no. ab6002) or mouse IgG (Sigma). Five μg of antibody
was used per 2 × 107cells. Immunoprecipitated com-
plexes were collected, washed and eluted using the
Dynal Magnetic Particle Concentrator (Invitrogen).
Eluted DNA and whole-cell extracts were incubated at
65°C in a rotating incubator for 8 hours to reverse
cross-links. DNA samples were sequentially treated with
RNase A and proteinase K and then purified by phenol/
chloroform extraction. The immunoprecipitated
(ChIPed) and purified DNA was ethanol precipitated
using glycogen as a carrier and resuspended in nucleic
acid grade water.
Methylated DNA immunoprecipitation (MeDIP)
MeDIP was performed according to the Agilent Microar-
ray Analysis of Methylated DNA Immunoprecipitation
protocol with modifications. Briefly, genomic DNA was
purified using SDS/Proteinase K incubation, phenol:
chloroform extraction, ribonuclease A incubation and
phenol:chloroform extraction followed by ethanol precipi-
tation. Purified genomic DNA was sonicated to 200-600
bp in size. Thirty μg sonicated DNA was incubated with
200 μl pan-mouse IgG Dynal magnetic beads (Invitrogen)
coupled to 20 μg antibody against 5’-methylcytosine
(Eurogentec, Seraing, Belgium) overnight at 4°C. The
genomic DNA-beads-antibody complex was washed and
methylated DNA was eluted using the Dynal Magnetic
Particle Concentrator. Eluted DNA and reference DNA
were extracted using phenol:chloroform:isoamylalcohol
and precipitated with ethanol.
Human promoter microarray profiling
For each microarray, 2 μg ChIPed DNA or MeDIPed
DNA and reference DNA were labeled with Cy3-dUTP
or Cy5-dUTP (GE Healthcare) using the CGH kit (Invi-
trogen). Human G4489A 2 × 244 k promoter arrays
(Agilent) were hybridized for 40 h at 65°C (for ChIP) or
67°C (for MeDIP) and subsequently scanned using an
Agilent Scanner controlled by Agilent Scan Control 7.0
software. Raw image files were extracted with Agilent
Feature Extraction 9.1 software.
Real-time quantitative PCR
Real-time quantitative PCR was performed to validate the
ChIP-chip and MeDIP-chip data using TaqMan assays
(Applied Biosystems, Foster City USA). The relative fold
enrichment of target regions was calculated based on the
differences in Ct values (ΔCt) between ChIPed or MeD-
IPed DNA and reference DNA that were pulled down by
mouse IgG. Fold change = 2ΔCt. Three biological and
technical replicates were done for each sample. All values
were expressed as mean ± standard deviation.
Global gene expression analysis
The Agilent Human Whole Genome (4 × 44 k) Oligo
Microarray with Sure Print Technology (Agilent Tech-
nologies, Palo Alto USA) was used to analyze samples in
the present study as previously described [4]. Quality and
yields of total RNA were assessed using the Agilent 2100
Bioanalyzer (Agilent Tech), 1% agarose gel ethidium bro-
mide electrophoresis and Powerwave spectrophotometry
at 260 nm and 280 nm. One μg of DNAse-treated total
RNA was converted into cDNA and Cy3-labeled cRNA
using the Low RNA Input Linear Amplification Kit
PLUS, One-Color kit (Agilent Tech.) according to
instructions. We used gmeansignals, i.e. signals without
background subtraction. Intraarray normalization of dye
effects was carried out using quantile normalization [34]
and genes with more than 25% missing values were
removed. The normalized signal values were log2
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transformed with cutoff 5 for the lowest level and 16 for
the highest level in gene expression. Data were formatted
in a J-Express-file suitable for additional data mining
(http://www.molmine.com/).
Gene ontology (GO) analysis
GO Analysis was performed as described previously
[5,13].
Data analysis
ChIP-chip and MeDIP-chip data were analyzed using
Agilent’s ChIP Analytics 1.3 software. Peaks were
detected using Whitehead Per-array Neighborhood
Model v1.0. Maximum distance for two probes to be con-
sidered as neighbors is 1000 bp, a probe is considered
“bound” if P(Xbar) < 0.001 and central probe has P(X) <
0.001 and at least one neighboring probe has P(X) < 0.1.
To achieve quantitative analysis of epigenetic modifica-
tions, total signal intensities of epigenetic marks were cal-
culated as follows: 1) All negative intensity values were
considered as zero. 2) All intensity values including pro-
moter and gene body of each gene were summarized. 3)
Genes with total intensities above 7 were defined as
marked genes. Mapping of bound probes was performed
using human genome HG17, May 2004.
Statistical analysis
Pearson’s Chi-square test was used in the analysis of the
correlation between epigenetic modification and gene
expression in prostate cells. The significance was defined
by a p-value ≤ 0.05. Differences were considered statisti-
cally significant for p < 0.05. All calculations were car-
ried out using the SPSS software.
Accession numbers
Gene Expression study ArrayExpress accession number:
E-TABM-949; ChIP-chip study ArrayExpress accession
numbers: E-TABM-635; E-TABM-983; MeDIP-chip
study ArrayExpress accession number: E-TABM-982.
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